ABVC financials
ABVC BioPharma (ABVC) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ABVC income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$7.15M | -$7.91M | -0.39 |
| 2024 | $509.59K | $508.83K | -$4.71M | -$4.90M | -0.42 |
| 2023 | $152.43K | -$149.61K | -$6.77M | -$7.79M | -1.80 |
| 2022 | $969.78K | $683.37K | -$15.11M | -$16.42M | -5.19 |
| 2021 | $355.80K | $350.71K | -$11.71M | -$12.84M | -5.10 |
| 2020 | $483.05K | $464.33K | -$8.51M | -$9.79M | -5.00 |